IPCA LABORATORIES
|
The Current P/S Ratio of IPCA LABORATORIES is 5.01.
| Share Price | ₹1,904.8 | Jul 17,2026 |
| Market Cap | ₹48,323.5 Cr | |
| Sales-TTM | ₹9,646.3 Cr | TTM-Consolidated Results |
| Price/Sales | 5.01x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of IPCA LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹48,323.5 Cr] as on Jul 17,2026
(/) Sales [ ₹9,646.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.01x ]
Thus, for IPCA LABORATORIES , the investors are currently willing to pay '5.01 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of IPCA LABORATORIES !
The chart below summarizes the trend in P/S Ratio of IPCA LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of IPCA LABORATORIES
PS Ratio Performance Analysis for IPCA LABORATORIES
- IPCA LABORATORIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 4.11x.
- IPCA LABORATORIES 's operated at median p/e ratio of 4.24x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, IPCA LABORATORIES 's p/e ratio peaked in Mar2022 at 4.64x.
- IPCA LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 3.31x.
How does IPCA LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| IPCA LABORATORIES | 9,646.3 | 5.01 | 48,323.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.93 | 463,815.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 18.25 | 192,678.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.54 | 161,323.0 |
| CIPLA LTD | 28,162.6 | 4.07 | 114,585.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.00 | 101,067.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.21 | 102,896.0 |
| LUPIN LTD | 27,958.0 | 3.99 | 111,661.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.20 | 113,990.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.62 | 88,265.9 |
| LAURUS LABS LTD | 6,812.9 | 12.13 | 82,639.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs IPCA LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.62x |
| Max industry PS | 18.25x |
| Median industry PS | 5.01x |
| Average industry PS | 7.27x |
You may also like the below Video Courses